| Literature DB >> 35558115 |
Adriana Blachowicz1, Snehit Mhatre1, Nitin Kumar Singh1, Jason M Wood1, Ceth W Parker1, Cynthia Ly1, Daniel Butler2, Christopher E Mason2,3, Kasthuri Venkateswaran1.
Abstract
Ensuring biological cleanliness while assembling and launching spacecraft is critical for robotic exploration of the solar system. To date, when preventing forward contamination of other celestial bodies, NASA Planetary Protection policies have focused on endospore-forming bacteria while fungi were neglected. In this study, for the first time the mycobiome of two spacecraft assembly facilities at Jet Propulsion Laboratory (JPL) and Kennedy Space Center (KSC) was assessed using both cultivation and sequencing techniques. To facilitate enumeration of viable fungal populations and downstream molecular analyses, collected samples were first treated with chloramphenicol for 24 h and then with propidium monoazide (PMA). Among cultivable fungi, 28 distinct species were observed, 16 at JPL and 16 at KSC facilities, while 13 isolates were potentially novel species. Only four isolated species Aureobasidium melanogenum, Penicillium fuscoglaucum, Penicillium decumbens, and Zalaria obscura were present in both cleanroom facilities, which suggests that mycobiomes differ significantly between distant locations. To better visualize the biogeography of all isolated strains the network analysis was undertaken and confirmed higher abundance of Malassezia globosa and Cyberlindnera jadinii. When amplicon sequencing was performed, JPL-SAF and KSC-PHSF showed differing mycobiomes. Metagenomic fungal reads were dominated by Ascomycota (91%) and Basidiomycota (7.15%). Similar to amplicon sequencing, the number of fungal reads changed following antibiotic treatment in both cleanrooms; however, the opposite trends were observed. Alas, treatment with the antibiotic did not allow for definitive ascribing changes observed in fungal populations between treated and untreated samples in both cleanrooms. Rather, these substantial differences in fungal abundance might be attributed to several factors, including the geographical location, climate and the in-house cleaning procedures used to maintain the cleanrooms. This study is a first step in characterizing cultivable and viable fungal populations in cleanrooms to assess fungal potential as biocontaminants during interplanetary explorations. The outcomes of this and future studies could be implemented in other cleanrooms that require to reduce microbial burden, like intensive care units, operating rooms, or cleanrooms in the semiconducting and pharmaceutical industries.Entities:
Keywords: amplicon sequencing; chloramphenicol; cleanroom; metagenome; mycobiome
Year: 2022 PMID: 35558115 PMCID: PMC9087587 DOI: 10.3389/fmicb.2022.777133
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Metadata of samples collected from JPL-SAF and KSC-PHSF.
| Facility/Location/ | Characteristics | Significance | Sample ID | Abbrev. name | Description | Date | Sampling method | Sampling area | Extraction volume (ml) |
| Jet Propulsion Laboratory Spacecraft Assembly Facility (JPL-SAF) Pasadena, CA West coast; dry desert like | ISO 7 (Class 10,000) HEPA Room Temperature: 20.4 ± 0.3°C Room Humidity: 45.5 ± 2% | Pathfinder (1997); Mars Exploration Rovers (2004); Mars Science Laboratory (2012); Perseverance (2020) | FD-01-001 | L1 | SW, near desk area and walkway to desk area | 4/17/2018 | BiSKit | 1 m2 | 45 |
| FD-01-002 | L2 | SW, corner between desk and front of unused door | |||||||
| FD-01-003 | L3 | SW, desk area & walking area to Cruise Stage | |||||||
| FD-01-004 | L4 | S, between cruise stage and Descent stage | |||||||
| FD-01-005 | L5 | Center, between desk and Descent stage | |||||||
| FD-01-006 | L6 | Center, walking area to desk behind monitor | |||||||
| FD-01-007 | L7 | W Center, next to center walkway, crane, and desk | |||||||
| FD-01-008 | L8 | SE, area in front of high bay spacecraft exit doors | |||||||
| 25 × 36 × 15 | FD-01-009 | L9 | Center, next to storage boxes in center of room | ||||||
| FD-01-010 | L10 | E, directly in front of room entrance, after tacky mat | |||||||
| FD-01-HC-01 | HC | Handling control (exposed to facility air) | — | ||||||
| FD-01-DC-01 | DC | Device control (moistened BiSKit, not used) | — | ||||||
| Kennedy Space Center Payload Hazardous Servicing Facility (KSC-PHSF) Cape Canaveral, FL East coast; swamp-like | ISO 7 (Class 10,000) HEPA Room Temperature: 21.7 ± 3.3°C Room Humidity: = 55% | Mars Exploration Rovers (2004); MarsReconn-AissanceOrbiter | FD-03-001 | L1 | SW, near airlock door for equipment storage moving | 6/12/2018 | BiSKit | 1 m2 | 45 |
| FD-03-002 | L2 | S center, between airlock entrance and exit into cleanroom | |||||||
| FD-03-003 | L3 | SE, near wall of high bay, grounding plate included | |||||||
| FD-03-004 | L4 | E center, left of grounding plate | |||||||
| FD-03-005 | L5 | Center, high bay center right | |||||||
| FD-03-006 | L6 | Center, high bay center left | |||||||
| FD-03-007 | L7 | W center, near west wall by fuel drain | |||||||
| FD-03-008 | L8 | NW, corner near west exit door 19 to outside | |||||||
| 33 × 18 × 29 | FD-03-009 | L9 | N center, front of door 18 | ||||||
| FD-03-010 | L10 | NE, front of door 17 | |||||||
| FD-03-HC-01 | HC | Handling control (exposed to facility air) | — | ||||||
| FD-03-DC-01 | DC | Device control (moistened BiSKit, not used) | — | ||||||
| FD-03-CM-01 | C1 | SW, alongside length of grate | ClipperMop | 10 m2 | 200 | ||||
| FD-03-CM-02 | C2 | Center, high bay center | |||||||
| FD-03-CM-03 | C3 | NE, between door 18 and 17 | |||||||
| FD-03-CM-HC | CHC | Handling control (exposed to facility air) | — | ||||||
| FD-03-CM-DC | CDC | Device control (moistened CM wipe, not used) | — | ||||||
| Kennedy Space Center Payload Hazardous Servicing Facility (KSC-PHSF) Cape Canaveral, FL East coast; swamp-like | ISO 7 (Class 10,000) HEPA Room Temperature: 21.7 ± 3.3°C Room Humidity: = 56% | Mars Exploration Rovers (2004); MarsReconn-AissanceOrbiter | FD-04-001 | L1 | SW, near airlock door for equipment storage moving | 7/24/2018 | BiSKit | 1 m2 | 45 |
| FD-04-002 | L2 | S center, between airlock entrance and exit into cleanroom | |||||||
| FD-04-003 | L3 | SE, near wall of high bay, grounding plate included | |||||||
| FD-04-004 | L4 | E center, left of grounding plate | |||||||
| FD-04-005 | L5 | Center, high bay center right | |||||||
| FD-04-006 | L6 | Center, high bay center left | |||||||
| FD-04-007 | L7 | W center, near west wall by fuel drain | |||||||
| FD-04-008 | L8 | NW, corner near west exit door 19 to outside | |||||||
| 33 × 18 × 29 | FD-04-009 | L9 | N center, front of door 18 | ||||||
| FD-04-010 | L10 | NE, front of door 17 | |||||||
| FD-04-HC-01 | HC | Handling Control (exposed to facility air) | — | ||||||
| FD-04-DC-01 | DC | Device control (moistened BiSKit, not used) | — | ||||||
| FD-04-CM-01 | C1 | SW, alongside length of grate | ClipperMop | 10 m2 | 200 | ||||
| FD-04-CM-02 | C2 | Center, high bay center | |||||||
| FD-04-CM-03 | C3 | NE, between door 18 and 17 | |||||||
| FD-04-CM-HC | CHC | Handling control (exposed to facility air) | — | ||||||
| FD-04-CM-DC | CDC | Device control (moistened CM wipe, not used) | — | ||||||
| Jet Propulsion Laboratory Spacecraft Assembly Facility (JPL-SAF) Pasadena, CA West coast; dry desert like | ISO 7 (Class 10,000) HEPA Room Temperature: 20.3 ± 0°C Room Humidity: 45.8 ± 0.1% | Pathfinder (1997); Mars Exploration Rovers (2004); Mars Science Laboratory (2012); Perseverance (2020) | FD-05-010 | L1 | SW, near desk area and walkway to desk area | 9/25/2018 | Wipe | 1 m2 | 45 |
| FD-05-005 | L7 | W Center, next to center walkway, crane, and desk | |||||||
| FD-05-003 | L9 | Center, next to storage boxes in center of room | |||||||
| FD-05-001 | L10 | E, directly in front of room entrance, after tacky mat | |||||||
| FD-05-002 | L11 | NE, desk area near entrance | |||||||
| FD-05-004 | L12 | SE, directly front of door to other airlock (unused) | |||||||
| FD-05-006 | L13 | N center, in front of cabinets | |||||||
| FD-05-007 | L14 | Center, between wheels of lift | |||||||
| FD-05-008 | L15 | NW, between GSE | |||||||
| 25× 36 × 15 | FD-05-009 | L16 | NW, between tool boxes | ||||||
| FD-05-HC-01 | HC | Handling control (exposed to facility air) | — | ||||||
| FD-05-DC-01 | DC | Device control (moistened wipe not used) | — | ||||||
| FD-05-CM-01 | C1 | E center, near entrance in front of solar panels | Wipe | 10 m2 | 200 | ||||
| FD-05-CM-02 | C2 | Center, near walkway | |||||||
| FD-05-CM-03 | C3 | E, alongside high bay spacecraft exit doors | |||||||
| FD-05-CM-HC | CHC | Handling control (exposed to facility air) | — | ||||||
| FD-05-CM-DC | CDC | Device control (moistened CM wipe, not used) | — |
FIGURE 1Viable fungal community profiles before and after antibiotic treatment. (A) Fungal genera assessed by amplicon sequencing. Numbers of total ITS reads and OTUs for each cleanroom and sampling event are indicated below each bar. (B) Fungal species assessed by shotgun metagenomic sequencing. Numbers of total and annotated metagenome reads are listed below each bar. JPL-1 stands for sampling at JPL-SAF on 17 April, 2018; JPL-2 corresponds to the second sampling of JPL-SAF on 25 September, 2018; KSC-1 refers to KSC-PHSF sampling on 12 June, 2018 and KSC-2 corresponds to KSC-PHSF sampling on 24 July, 2018; AB/noAB indicates presence or absence of the antibiotic treatment.
FIGURE 2Functional guilds of identified viable fungi. To determine the “ecology” of reported fungal genera and species FUNGuild analysis was performed on (A) amplicon and (B) metagenome reads, respectively. Identified guild categories are presented. NA, not applicable.
FIGURE 3Spatial distribution of viable fungi in samples treated with chloramphenicol at JPL-SAF. JPL-SAF sampling on 17 April, 2018 is marked in orange and on 25 September, 2018 in blue. The locations, marked L1-L16 and C1-C3, indicate areas sampled during the first and second sampling. Locations sampled in the second sampling had to be adjusted to account for on-going M2020 activities. Fungal taxa, GenBank accession #, sampling location, and ITS reads are indicated in the tables. L indicates locations sampled with BiSKit or wipe, while C indicates locations sampled with ClipperMop.
FIGURE 4Spatial distribution of viable fungi in samples treated with chloramphenicol at KSC-PHSF. KSC-PHSF sampling on 12 June, 2018 is marked in green and on 24 July, 2018 in violet. A schematic diagram depicts from where samples were collected during both sampling events. Locations are marked as L1–L10 and C1–C3. Fungal taxa, GenBank accession #, sampling location, and ITS reads are indicated in the tables. L indicates locations sampled with BiSKit, while C indicates locations sampled with ClipperMop.
FIGURE 5Canonical correspondence analysis (CCA) revealing relationships among fungal populations and associated cleanroom environments. Presented is the distribution of viable fungal taxa in both cleanrooms during consecutive sampling events assessed by amplicon sequencing. Glyphs are colored based on the sampling event. Colored ellipses are included for each sampling event to represent the standard error of the mean of each cluster (99% confidence). CCA axes include the percent variation described by the axis. JPL-1 stands for sampling at JPL-SAF on 17 April, 2018; JPL-2 corresponds to the second sampling of JPL-SAF on 25 September, 2018; KSC-1 refers to KSC-PHSF sampling on 12 June, 2018 and KSC-2 corresponds to KSC-PHSF sampling on 24 July, 2018.
ANOSIM and Mann-Whitney-Wilcoxon analyses of viable amplicon reads at genus level of all antibiotic treated and not treated samples (A) and samples separated by location and sampling event with chloramphenicol (B).
| (A) Antibiotic vs. no antibiotic. | |||||
|
| |||||
| MWW | ANOSIM | ||||
|
| |||||
|
| |||||
|
| |||||
|
|
|
|
|
| |
|
| |||||
| JPL-1 | |||||
|
| |||||
| JPL-2 |
| ||||
|
| |||||
| KSC-1 | |||||
|
| |||||
| KSC-2 | |||||
|
| |||||
|
| |||||
FIGURE 6Viable fungal taxa ordinate analysis of samples from JPL-SAF and KSC-PHSF. (A) To determine the impact of the chloramphenicol treatment on the fungal diversity, normalized amplicon reads of antibiotic treated and untreated samples were analyzed. Tested indices include (i) Chao1 diversity analysis (ii) Shannon index (iii) Simpson index, and (iv) Venn diagram. (B) Location/sampling event-based diversity was assessed using amplicon reads of antibiotic treated samples only. Tested indices include (i) Chao1 diversity analysis, (ii) Shannon index, (iii) Simpson index, and (iv) Venn diagram showing the distribution of viable fungal taxa. JPL-1 stands for sampling at JPL-SAF on 17 April, 2018; JPL-2 corresponds to the second sampling of JPL-SAF on 25 September, 2018; KSC-1 refers to KSC-PHSF sampling on 12 June, 2018 and KSC-2 corresponds to KSC-PHSF sampling on 24 July, 2018; AB/noAB indicates presence or absence of the antibiotic treatment.
FIGURE 7Network analysis presenting biogeographical distribution of viable fungal populations after antibiotic treatment. (A) Presented are the most abundant (abundance > 0.01% of all reads) fungal species in JPL-SAF and KSC-PHSF. (B) The most abundant fungal reads are assigned to sampled locations. The thickness and transparency of the edges (lines) follows the calculated e-weights. JPL-1 stands for sampling at JPL-SAF on 17 April, 2018; JPL-2 corresponds to the second sampling of JPL-SAF on 25 September, 2018; KSC-1 refers to KSC-PHSF sampling on 12 June, 2018 and KSC-2 corresponds to KSC-PHSF sampling on 24 July, 2018. In (B), sampling locations are marked using the system that indicates sampled cleanroom at JPL or KSC marked as J or K, first or second sampling event indicated by 1 or 2, followed by sampled location labeled as L1–L10, for example, J1L2 stands for JPL-SAF first sampling at location 2. The red colored taxa were more abundant in control samples.
ANOSIM and Mann-Whitney-Wilcoxon analyses of viable metagenome reads at species level of all antibiotic treated and not treated samples (A) and samples separated by location and sampling event with chloramphenicol (B).
| (A) Antibiotic vs. no antibiotic. | |||||
|
| |||||
| MWW | ANOSIM | ||||
|
| |||||
|
| |||||
|
| |||||
|
|
|
|
|
| |
|
| |||||
| JPL-1 | |||||
|
| |||||
| JPL-2 |
| ||||
|
| |||||
| KSC-1 | |||||
|
| |||||
| KSC-2 | |||||
|
| |||||
|
| |||||
FIGURE 8Species-level ordinate analysis of samples from JPL-SAF and KSC-PHSF cleanrooms. (A) To determine the impact of the chloramphenicol treatment on the fungal diversity, normalized metagenomic reads of antibiotic treated and untreated samples were analyzed. Tested indices include (i) Chao1 diversity analysis (ii) Shannon index (iii) Simpson index, and (iv) Venn diagram. (B) Location/sampling event-based diversity was assessed using metagenomic reads of antibiotic treated samples only. Tested indices include (i) Chao1 diversity analysis, (ii) Shannon index, (iii) Simpson index, (iv) Venn diagram showing the distribution of viable fungal taxa. JPL-1 stands for sampling at JPL-SAF on 17 April, 2018; JPL-2 corresponds to the second sampling of JPL-SAF on 25 September, 2018; KSC-1 refers to KSC-PHSF sampling on 12 June, 2018 and KSC-2 corresponds to KSC-PHSF sampling on 24 July, 2018; AB/noAB indicates presence or absence of the antibiotic treatment.
FIGURE 9Analysis of metagenomic reads from JPL-SAF and KSC-PHSF cleanrooms. Presented are the most abundant genes/proteins in both cleanrooms during consecutive sampling events assessed by shotgun metagenomics. JPL-1 stands for sampling at JPL-SAF on 17 April, 2018; JPL-2 corresponds to the second sampling of JPL-SAF on 25 September, 2018; KSC-1 refers to KSC-PHSF sampling on 12 June, 2018 and KSC-2 corresponds to KSC-PHSF sampling on 24 July, 2018; AB/noAB indicates presence or absence of the antibiotic treatment.
Functional analysis of viable metagenome reads of all antibiotic treated and not treated samples.
| EggNog | Putative function/activity | JPL-1 no AB | JPL-1 AB | JPL-2 no AB | JPL-2 AB | KSC-1 no AB | KSC-1 AB | KSC-2 no AB | KSC-2 AB |
| ENOG410XNQK | Transporter | 4 | 0 | 77 | 87 | 5 | 1,647 | 32 | 31 |
| COG0477 | Major facilitator Superfamily | 6 | 0 | 65 | 57 | 10 | 1,369 | 11 | 29 |
| COG2801 | Retrotransposon protein | 0 | 0 | 5 | 8 | 52 | 1,377 | 5 | 4 |
| COG2124 | Cytochrome p450 | 0 | 0 | 99 | 68 | 12 | 994 | 13 | 30 |
| COG3321 | Synthase | 0 | 0 | 27 | 29 | 13 | 944 | 4 | 15 |
| COG1020 | Non-ribosomal peptide synthetase | 0 | 0 | 31 | 20 | 4 | 774 | 2 | 4 |
| COG0531 | Amino acid | 6 | 0 | 37 | 23 | 0 | 561 | 15 | 13 |
| COG1131 | (ABC) transporter | 0 | 0 | 37 | 37 | 9 | 532 | 0 | 17 |
| COG1132 | (ABC) transporter | 0 | 0 | 39 | 50 | 6 | 445 | 11 | 20 |
| COG0474 | P-type ATPase | 2 | 0 | 20 | 17 | 12 | 399 | 7 | 18 |
| COG5032 | Phosphatidylinositol kinase | 3 | 0 | 25 | 30 | 9 | 376 | 8 | 22 |
| COG1472 | Hydrolase family 3 | 0 | 0 | 35 | 17 | 14 | 334 | 4 | 2 |
| COG1012 | Dehydrogenase | 0 | 0 | 11 | 20 | 1 | 355 | 2 | 15 |
| COG2303 | Oxidoreductase | 7 | 0 | 16 | 17 | 0 | 333 | 8 | 17 |
| COG0654 | Xidoreductase | 2 | 0 | 19 | 19 | 6 | 317 | 2 | 10 |
| COG2072 | Monooxygenase | 0 | 0 | 9 | 10 | 6 | 338 | 1 | 2 |
| COG0366 | Alpha amylase, catalytic | 2 | 0 | 17 | 12 | 0 | 306 | 5 | 9 |
| COG0464 | AAA ATPase | 1 | 0 | 25 | 40 | 0 | 269 | 8 | 5 |
| COG0604 | Alcohol dehydrogenase | 0 | 0 | 18 | 11 | 0 | 284 | 2 | 10 |
| COG1215 | Glycosyl transferase, family | 0 | 0 | 42 | 30 | 6 | 211 | 1 | 14 |
| COG1112 | Helicase | 3 | 0 | 14 | 30 | 0 | 247 | 1 | 8 |
| COG0277 | FAD linked oxidase | 0 | 0 | 6 | 9 | 4 | 258 | 2 | 11 |
| COG1643 | Helicase | 1 | 0 | 43 | 36 | 4 | 189 | 4 | 10 |
| COG0318 | Amp-dependent synthetase and ligase | 2 | 0 | 31 | 22 | 0 | 214 | 5 | 7 |
| COG5059 | Kinesin family member | 0 | 0 | 8 | 12 | 9 | 235 | 7 | 6 |
| ENOG410XRBH | SRSF protein kinase | 0 | 0 | 27 | 11 | 0 | 235 | 0 | 3 |
| COG3320 | Domain protein | 1 | 0 | 16 | 4 | 8 | 230 | 3 | 0 |
| COG1501 | Hydrolase, family 31 | 0 | 0 | 6 | 8 | 1 | 238 | 2 | 6 |
| COG2272 | Carboxylesterase | 0 | 0 | 6 | 5 | 0 | 243 | 0 | 1 |
| ENOG410XNPJ | Polyketide synthase | 0 | 0 | 1 | 2 | 7 | 240 | 0 | 2 |